Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
Clara K Chow, Chinthanie Ramasundarahettige, Weihong Hu, et al.
The Lancet Diabetes & Endocrinology (2018) Vol. 6, Iss. 10, pp. 798-808
Closed Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
Marjan Walli-Attaei, Philip Joseph, Annika Rosengren, et al.
The Lancet (2020) Vol. 396, Iss. 10244, pp. 97-109
Closed Access | Times Cited: 267
Estimation of global insulin use for type 2 diabetes, 2018–30: a microsimulation analysis
Sanjay Basu, John Yudkin, Sylvia Kehlenbrink, et al.
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 1, pp. 25-33
Open Access | Times Cited: 192
Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
Sachin Khunti, Kamlesh Khunti, Samuel Seidu
Therapeutic Advances in Endocrinology and Metabolism (2019) Vol. 10
Open Access | Times Cited: 153
The costs of diabetes treatment in low- and middle-income countries: a systematic review
Corrina Moucheraud, Cosima Lenz, Michaella Latkovic, et al.
BMJ Global Health (2019) Vol. 4, Iss. 1, pp. e001258-e001258
Open Access | Times Cited: 149
Cardiovascular outcomes in type 1 and type 2 diabetes
Annika Rosengren, Pigi Dikaiou
Diabetologia (2023) Vol. 66, Iss. 3, pp. 425-437
Open Access | Times Cited: 80
Global accessibility of therapeutics for diabetes mellitus
Michael Fralick, Alicia J. Jenkins, Kamlesh Khunti, et al.
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 4, pp. 199-204
Open Access | Times Cited: 78
Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990–2019 data
Jinli Liu, Ruhai Bai, Zhonglin Chai, et al.
Diabetologia (2022) Vol. 65, Iss. 8, pp. 1339-1352
Open Access | Times Cited: 76
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020
John W. Ostrominski, Suzanne V. Arnold, Javed Butler, et al.
JAMA Cardiology (2023) Vol. 8, Iss. 11, pp. 1050-1050
Open Access | Times Cited: 63
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
Bin Zhou, A. Rayner, Edward W. Gregg, et al.
The Lancet (2024) Vol. 404, Iss. 10467, pp. 2077-2093
Open Access | Times Cited: 55
The Global Burden of Diabetes
Jessica L. Harding, Mary Beth Weber, Jonathan E. Shaw
(2024), pp. 28-40
Closed Access | Times Cited: 50
The role of structural racism and geographical inequity in diabetes outcomes
Shivani Agarwal, Alisha N. Wade, Jean Claude Mbanya, et al.
The Lancet (2023) Vol. 402, Iss. 10397, pp. 235-249
Open Access | Times Cited: 43
Insulin prices, availability and affordability in 13 low-income and middle-income countries
Margaret Ewen, Huibert-Jan Joosse, David Beran, et al.
BMJ Global Health (2019) Vol. 4, Iss. 3, pp. e001410-e001410
Open Access | Times Cited: 104
Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
Clara K Chow, Tu Ngoc Nguyen, Simone Marschner, et al.
BMJ Global Health (2020) Vol. 5, Iss. 11, pp. e002640-e002640
Open Access | Times Cited: 93
The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries—a review of the current literature
Cindy George, Justin B. Echouffo‐Tcheugui, Bernard G. Jaar, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 53
Health supply chain system in Uganda: current issues, structure, performance, and implications for systems strengthening
Eric Lugada, Henry Komakech, Irene Ochola, et al.
Journal of Pharmaceutical Policy and Practice (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 47
Resmetirom for MASH patients with diabetes: challenges and opportunities in the real world
Li-You Lian, Giovanni Targher, Christopher D. Byrne, et al.
Metabolism (2024) Vol. 156, pp. 155935-155935
Closed Access | Times Cited: 11
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
Yi Song, Jian Li, Yuzhang Wu
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries
Muhammad Daoud Butt, Siew Chin Ong, A. Rafiq, et al.
Journal of Pharmaceutical Policy and Practice (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Diabetes mellitus tipo 2 en Perú: una revisión sistemática sobre la prevalencia e incidencia en población general
Rodrigo M. Carrillo‐Larco, Antonio Bernabé‐Ortiz
Revista Peruana de Medicina Experimental y Salud Pública (2019) Vol. 36, Iss. 1, pp. 26-26
Open Access | Times Cited: 71
Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment
Viswanathan Mohan, Kamlesh Khunti, Siew Pheng Chan, et al.
Diabetes Therapy (2019) Vol. 11, Iss. 1, pp. 15-35
Open Access | Times Cited: 65
A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia
Kurubaran Ganasegeran, Chee Peng Hor, Mohd Fadzly Amar Jamil, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 16, pp. 5723-5723
Open Access | Times Cited: 53
The WHO Global Diabetes Compact: a new initiative to support people living with diabetes
Daniel Hunt, Bianca Hemmingsen, Alena Matzke, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 6, pp. 325-327
Closed Access | Times Cited: 53
Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data
David Flood, Pascal Geldsetzer, Kokou Agoudavi, et al.
Diabetes Care (2022) Vol. 45, Iss. 9, pp. 1961-1970
Open Access | Times Cited: 31
2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care
Samuel Seidu, Xavier Cos, Stephen Brunton, et al.
Primary care diabetes (2022) Vol. 16, Iss. 2, pp. 223-244
Open Access | Times Cited: 30
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second‐line therapy: Results from the global DISCOVER study programme
Antonio Nicolucci, B Charbonnel, Marília Brito Gomes, et al.
Diabetes Obesity and Metabolism (2019) Vol. 21, Iss. 11, pp. 2474-2485
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top